Laurent M. Humeau
2019
In 2019, Laurent M. Humeau earned a total compensation of $972.5K as Chief Scientific Officer at Inovio Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $165,760 |
|---|---|
| Option Awards | $200,970 |
| Salary | $393,903 |
| Stock Awards | $199,398 |
| Other | $12,500 |
| Total | $972,531 |
Humeau received $393.9K in salary, accounting for 41% of the total pay in 2019.
Humeau also received $165.8K in non-equity incentive plan, $201K in option awards, $199.4K in stock awards and $12.5K in other compensation.
Rankings
In 2019, Laurent M. Humeau's compensation ranked 9,394th out of 13,971 executives tracked by ExecPay. In other words, Humeau earned more than 32.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,394 out of 13,971 | 33rd |
Division Manufacturing | 3,768 out of 5,701 | 34th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 498 out of 832 | 40th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 303 out of 535 | 43rd |
Industry Surgical and Medical Instruments and Apparatus | 194 out of 350 | 45th |
Source: SEC filing on March 25, 2021.
Humeau's colleagues
We found three more compensation records of executives who worked with Laurent M. Humeau at Inovio Pharmaceuticals in 2019.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021